Loading...
Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation
BACKGROUND AND OBJECTIVES: All randomized trials of direct oral anticoagulants in atrial fibrillation excluded patients with severe kidney disease. The safety and effectiveness of direct oral anticoagulants across the range of eGFR in real-world settings is unknown. Our objective is to quantify the...
Na minha lista:
| Udgivet i: | Clin J Am Soc Nephrol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Nephrology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6086708/ https://ncbi.nlm.nih.gov/pubmed/30002224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.13811217 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|